Doctor's Data Inc

Toxigenic C. difficile DNA; stool

A stool specimen or an isolated sample of C. difficile is tested for all known toxigenic strains using an FDA-cleared, molecular diagnostic DNA assay. This test is available as a stand-alone test, or included automatically at no additional charge any time C. difficile is cultured at any level in our other Clostridium cultures.
Learn more »

Turnaround Time

2 to 4 days

Analytes Tested

Click any analyte name for additional clinical information, including reference ranges, specimen collection, stability and rejection criteria.

Analyte CPT ABN Required
Toxigenic C. Difficile DNA; stool 87493 No

List price applies when filing with insurance or Medicare, or when billing a patient directly.

Prompt payment pricing applies when billing to a physician account or prepayment is received with the test.

Doctor's Data offers profiles containing multiple analytes. *Multiple analytes may be billed under a single CPT code. Many analytes can be ordered individually. Pricing may vary. Click on a specific analyte for more information or read our detailed billing and payment policies.

The CPT codes listed on our website are for informational purposes only. This information is our interpretation of CPT coding requirements and may not necessarily be correct. You are advised to consult the CPT Coding Manual published by the American Medical Association. Doctor's Data, Inc. takes no responsibility for billing errors due to your use of any CPT information from our website.

Sign in at the top of any page to view pricing and order tests. Or click here to create an account. You may also contact us for assistance placing an order.

This test is useful for

  • Antibiotic-Associated Diarrhea
  • Autism Spectrum Disorders

Detailed Information

For this assessment, a stool specimen or an isolated sample of C. difficile is tested for all known toxigenic strains using an FDA-cleared, molecular diagnostic DNA assay. This test is available as a stand-alone, or included automatically at no additional charge any time C. difficile is cultured at any level in our other Clostridium cultures.

Clostridia generally are resistant to antibiotics and treatment of an overgrowth of C. difficile, especially in asymptomatic carriers and infants under age two, is usually not warranted. Additionally, since plasmids have a potential role in transferring various capacities, including antibiotic resistance, from one organism to another, the use of antibiotics in the treatment of clostridia overgrowth should be considered carefully.

Clinical Microbiology

Find out more